ChestAi - About the company
ChestAi is an unfunded company based in New Haven (United States), founded in 2019. It operates as a Provider of AI-based image analysis of chest diseases. ChestAi has not raised any funding yet. The company has 747 active competitors, including 163 funded and 42 that have exited. Its top competitors include companies like AIdoc, Subtle Medical and ScreenPoint.
Company Details
Chest AI provides an AI-based image analysis for chest diseases. The application can detect the diagnosis of each of the chest diseases through the analysis of the image taken from the mobile phone.
- Website
- www.chestai.org/
- Email ID
- *****@chestai.com
Key Metrics
Founded Year
2019
Location
New Haven, United States
Stage
Unfunded
Ranked
488th among 747 active competitors
Similar Companies
Sign up to download ChestAi's company profile
ChestAi's funding and investors
ChestAi has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
ChestAi's Competitors and alternates
Top competitors of ChestAi include AIdoc, Subtle Medical and ScreenPoint. Here is the list of Top 10 competitors of ChestAi, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  AIdoc 2016, New York City (United States), Series E | Developer of clinical AI solutions for healthcare imaging and patient management | $534M | 69/100 | |
2nd |  Subtle Medical 2017, Palo Alto (United States), Series C | AI-driven solutions for medical diagnostic imaging | $86M | 65/100 | |
3rd | ScreenPoint 2014, Nijmegen (Netherlands), Series C | Developer of artificial intelligence software for analyzing breast imaging mammograms | $47M | 64/100 | |
4th |  Cleerly 2016, Denver (United States), Series C | Provider of an AI-driven platform for coronary artery disease assessment | $578M | 63/100 | |
5th |  Vista 2012, Palo Alto (United States), Series B | AI-guided software for clinicians to automate MRI exams | $38.2M | 62/100 | |
6th | AI-powered radiology and deployment platform | $16M | 62/100 | ||
7th | IXICO 2004, London (United Kingdom), Public | AI-based medical image management and analysis solutions for healthcare organizations | - | 62/100 | |
8th | Provider of AI-based breast cancer screening software for clinics | $20.3M | 61/100 | ||
9th | AI-powered tool for the detection of heart risk | $19.1M | 61/100 | ||
10th |  AI Medical Service 2017, Toshima City (Japan), Series C | AI-powered endoscopic software to detect early-stage gastrointestinal cancers | $122M | 60/100 | |
488th | ChestAi 2019, New Haven (United States), Unfunded | Provider of AI-based image analysis of chest diseases | - | - | 24/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on ChestAi's competitors? Click here to see the top ones
ChestAi's Investments and acquisitions
ChestAi has made no investments or acquisitions yet.
Reports related to ChestAi
Here is the latest report on ChestAi's sector:
Are you a Founder ?
FAQs about ChestAi
Explore our recently published companies
- Global Transition - Djibouti based, Unfunded company
- Trading With Vivek - Unfunded company
- Kobold Manufaktur - Germany based, Unfunded company
- RijReclame - Almere based, 2026 founded, Unfunded company
- Avenue B - Richmond based, Unfunded company
- Solinide Photonics - Partille based, Unfunded company
